« Previous
Next »
Journal of Reproductive Immunology
Volume 86, Issue 2
, Pages 122-125
, November 2010
Soluble CD30 in normotensive pregnant women with isolated fetal intrauterine growth restriction: a comparison with preeclamptic women
References
- . Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses; comparison with preeclampsia. Br. J. Obstet. Gynaecol. 2001;108:1277–1282
- . How B and T cells talk to each other. Nature. 1994;367:425
- . Presence of CD30+ and CD30L+ cells in human placenta and soluble CD30 levels in cord blood are independent of maternal atopy. Placenta. 2001;22:372–379
- . Fetal growth retardation in infants of multiparous women with preeclampsia. Am. J. Obstet. Gynecol. 1993;169:1112–1118
- . Soluble CD30 (sCD30) in normal pregnancy, preeclampsia and recurrent spontaneous abortion (RSA). J. Reprod. Immunol. 2009;81:164;(Abstract P26)
- . CD30 expression does not discriminate between human Th1- and Th2-type T cells. J. Immunol. 1996;156:1387–1391
- . Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies. J. Matern. Fetal Neonatal. Med. 2007;20(12):867–878
- . In vitro differentiation of villous trophoblasts from pregnancies complicated by intrauterine growth restriction with and without preeclampsia. Placenta. 2007;28:999–1003
- . Recent insights into the pathogenesis of preeclampsia. Placenta. 2002;23:359–372
- . Regulatory cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin. Immunopathol. 2007;29:115–122
PII: S0165-0378(10)00099-9
doi: 10.1016/j.jri.2010.05.004
© 2010 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Journal of Reproductive Immunology
Volume 86, Issue 2
, Pages 122-125
, November 2010
